Ausgabe 4/2018
Inhalt (15 Artikel)
ÖGRO survey on radiotherapy capacity in Austria
Brigitte Zurl, Anja Bayerl, Alexander De Vries, Hans Geinitz, Robert Hawliczek, Tomas-Henrik Knocke-Abulesz, Peter Lukas, Richard Pötter, Wolfgang Raunik, Brigitte Scholz, Annemarie Schratter-Sehn, Felix Sedlmayer, Dietmar Seewald, Edgar Selzer, Karin S. Kapp
Quality of training in radiation oncology in Germany: where do we stand?
C. T. Dietzel, K. Jablonska, M. Niyazi, T. Gauer, N. Ebert, C. Ostheimer, D. Krug
Patterns of relapse as determined by 68Ga-PSMA ligand PET/CT after radical prostatectomy
Christoph Henkenberens, Thorsten Derlin, Frank M. Bengel, Tobias L. Ross, Hans-Jürgen Wester, Katja Hueper, Markus A. Kuczyk, Hans Christiansen, Christoph A. von Klot
Long-term outcomes in patients younger than 60 years of age treated with brachytherapy for prostate cancer
Pedro J. Prada, Juan Cardenal, Ana García Blanco, Javier Anchuelo, María Ferri, Ivan Diaz de Cerio, Andrés Vázquez, Maite Pacheco, Samuel Ruiz Arrebola
Oligometastases in prostate cancer
René Baumann, Mark Koncz, Ulf Luetzen, Fabian Krause, Juergen Dunst
Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy
Gunnar Lohm, Konrad Neumann, Volker Budach, Thomas Wiegel, Stefan Hoecht, Johannes Gollrad
Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy
Martin Buschmann, Abdul Wahab M. Sharfo, Joan Penninkhof, Yvette Seppenwoolde, Gregor Goldner, Dietmar Georg, Sebastiaan Breedveld, Ben J. M. Heijmen
Recovery from sublethal damage and potentially lethal damage
Shingo Hashimoto, Chikao Sugie, Hiromitsu Iwata, Hiroyuki Ogino, Chihiro Omachi, Keisuke Yasui, Jun-etsu Mizoe, Yuta Shibamoto
Kommentar zu „T1–2 glottic cancer treated with radiotherapy and/or surgery“
Christopher Bohr
Retrospective inconsistent analysis cannot validate safety of a treatment strategy
Vratislav Strnad
Nivolumab für das vorbehandelte metastasierte Analkarzinom
Daniel Martin, Claus Rödel, Emmanouil Fokas
Kombination aus perkutaner Strahlentherapie, Brachytherapie und Androgendeprivation gleichwertige Alternative zur radikalen Prostatektomie beim Prostatakarzinom
Constantinos Zamboglou, Anca Ligia Grosu
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer
Olarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, Minglun Li, Maurice Dantes, Julian Taugner, Amanda Tufman, Rudolf Maria Huber, Claus Belka, Farkhad Manapov